141st APHA Annual Meeting

In This section

281144
Efficacy of adapted personalized cognitive counseling (PCC) for high-risk, HIV-negative, episodic substance-using MSM: Findings from project echo

Wednesday, November 6, 2013

Phillip Coffin, MD, MIA , Substance Use Research Unit, San Francisco Department of Public Health, San Francisco, CA
Glenn-Milo Santos, MPH , Department of Epidemiology and Biostatistics, University of California - San Francisco School of Medicine, San Francisco, CA
Moupali Das, MD, MPH , HIV Prevention, San Francisco Department of Public Health, San Francisco, CA
Tim Matheson, PhD , HIV Prevention, San Francisco Department of Public Health, San Francisco, CA
Erin DeMicco, MPH , HIV Prevention, San Francisco Department of Public Health, San Francisco, CA
Jeffrey H. Herbst, PhD , Prevention Research Branch, US Centers for Disease Control and Prevention, Atlanta, GA
Jerris L. Raiford, PhD , CCID/NCHHSTP/Division of HIV/AIDS Prevention/Prevention Research Branch, Centers for Disease Control and Prevention, Atlanta, GA
Monique Carry, PhD , Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA
James Dilley, MD , Department of Psychiatry, University of California, San Francisco, San Francisco, CA
Eric Vittinghoff, PhD , Department of Biostatistics, University of California San Francisco, San Francisco, CA
Background: Episodic drug use and binge drinking are associated with sexual HIV risk behaviors among substance-using men who have sex with men (SUMSM), yet no evidence‐based HIV prevention interventions exist for these men. We adapted personalized cognitive counseling (PCC), addressing rationalizations for high-risk behavior, to SUMSM and evaluated the intervention. Methods: We conducted a randomized controlled trial (N=326) to test the efficacy of adapted PCC among HIV-negative, episodic SUMSM reporting recent UAI and concurrent use of methamphetamine, poppers, cocaine, or binge-drinking in the past 3 months. PCC participants (n=164) received HIV testing plus 2 counseling sessions; control participants (n=162) received HIV testing. Primary outcomes included number of UAI events, UAI partners, and UAI events with three most-recent non-primary partners. We examined linear trends in treatment effect using GEE Poisson models with robust standard errors and conducted sub-group analyses excluding 138 participants actually substance dependent at baseline. Results: Mean age was 33.6 years, 49% were white, 10% African American, 26% Latino; 96% completed 3 and 6 month follow-up. We observed parallel reductions in mean UAI events [PCC = 2.0 (4.7); control = 1.8 (4.4)], but no significant intervention effects in primary outcomes. For non-substance dependent men, UAI events with 3 most-recent non-primary partners declined among participants in PCC compared to control (RR=0.56, 0.34-0.92). Conclusion: We did not find evidence that adapted PCC was efficacious in reducing sexual risk behaviors in the overall sample, yet did observe a reduction in UAI events with recent partners among SUMSM not dependent on target substances.

Learning Areas:
Basic medical science applied in public health
Public health or related research
Social and behavioral sciences

Learning Objectives:
Explain results of the randomized trial of adapted personalized cognitive counseling for substance-using men-who-have-sex-with-men. Describe personalized cogntive counseling.

Keywords: Substance Abuse, Behavioral Research

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am the principal investigator on this study. I direct the Substance Use Research Unit, which focuses on clinical studies to reduce substance use and associated HIV risk behaviors among MSM.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.